Belysse: two co-options to the board, including a Lone Star representative
The Belgian manufacturer of textile floor coverings has appointed a vice-president of Hudson Advisors UK Limited to its board of directors, a company that advises notably Lone Star Fund IX, an investor in the group. An independent director now sits through her company, Aequilux SRL. The two co-options took effect on October 22 and 23, 2026.
Philip Augsburger takes over Neal Morar's term
Philip Augsburger joined the board of directors of Belysse Group NV on October 22, 2026 as a non-executive director, by way of co-option. He sits for the remaining duration of Neal Morar's mandate, who left his position as board member on the same date. The board of directors thanked Neal Morar for his contribution.
Philip Augsburger is vice-president of Hudson Advisors UK Limited, which advises Lone Star Funds, including Lone Star Fund IX, an investor in the company. He previously worked in investment banking at Bank of America and held financial positions at Rheem Manufacturing Company in the United States and Australia. He holds an MBA from IESE Business School and a Bachelor of Business Administration in Finance from Texas Tech University.
Vanessa Temple now represents Aequilux SRL on the board
Aequilux SRL, represented by its permanent representative Vanessa Temple, has been appointed as an independent director of Belysse Group NV by way of co-option as of October 23, 2026. The company replaces Vanessa Temple, who sat in a personal capacity, for the remaining duration of her mandate.
The mandates of Philip Augsburger and Aequilux SRL run until the shareholders' general meeting in 2029 inclusive. They will be subject to confirmation at the next shareholders' general meeting.
Based in Waregem, Belysse employs nearly 1,000 people across three production sites (Tielt and Zele in Belgium, Los Angeles in the United States). The group markets its products mainly in North America and Europe under the Bentley, Modulyss and ITC brands, and achieved revenue of €254.2 million in 2025.
